X0202 SCHEDULE 13G 0001930214 XXXXXXXX LIVE Common Stock, par value $0.001 per share 07/06/2026 0000949858 Achieve Life Sciences, Inc. 004468500 22722 29th Drive SE, Suite 100 Bothell WA 98021 Rule 13d-1(c) Vivo Opportunity Fund Holdings, L.P. b DE 1944430.00 0.00 1944430.00 0.00 1944430.00 N 1.8 PN The reported share amount represents an aggregate of (i) 972,215 shares of common stock, par value $0.001 per share (the "Common Stock") of Achieve Life Sciences, Inc. (the "Issuer"), and (ii) 972,215 shares of Common Stock of the Issuer, which are issuable upon the exercise of certain warrants. The shares of Common Stock and warrants are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. The percentage reported in row 11 herein is based on 105,410,089 shares of Common Stock of the Issuer outstanding, which is the sum of (i) 102,659,057 shares of Common Stock outstanding as of May 15, 2026, as reported by the Issuer in its proxy statement on Form DEF 14A, filed with the Securities and Exchange Commission (the "SEC") on June 8, 2026, and (ii) an aggregate of 2,751,032 shares of Common Stock issuable upon the exercise of warrants held by all the reporting persons. The warrants contain provisions that prevent these securities from being exercised into shares of Common Stock, if such exercise would result in the holder or its affiliates obtaining greater than 9.99% of the Issuer's voting securities. Vivo Opportunity Co-Invest, L.P. b DE 1220358.00 0.00 1220358.00 0.00 1220358.00 N 1.2 PN The reported share amount represents an aggregate of (i) 610,179 shares of Common Stock of the Issuer, and (ii) 610,179 shares of Common Stock of the Issuer, which are issuable upon the exercise of certain warrants. The shares of Common Stock and warrants are held of record by Vivo Opportunity Co-Invest, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Co-Invest, L.P. The percentage reported in row 11 herein is based on 105,410,089 shares of Common Stock of the Issuer outstanding, which is the sum of (i) 102,659,057 shares of Common Stock outstanding as of May 15, 2026, as reported by the Issuer in its proxy statement on Form DEF 14A, filed with the SEC on June 8, 2026, and (ii) an aggregate of 2,751,032 shares of Common Stock issuable upon the exercise of warrants held by all the reporting persons. The warrants contain provisions that prevent these securities from being exercised into shares of Common Stock, if such exercise would result in the holder or its affiliates obtaining greater than 9.99% of the Issuer's voting securities. Vivo Opportunity Co-Invest (Cycle 3), L.P. b DE 2140852.00 0.00 2140852.00 0.00 2140852.00 N 2.0 PN The reported share amount represents an aggregate of (i) 1,070,426 shares of Common Stock of the Issuer, and (ii) 1,070,426 shares of Common Stock of the Issuer, which are issuable upon the exercise of certain warrants. The shares of Common Stock and warrants are held of record by Vivo Opportunity Co-Invest (Cycle 3), L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Co-Invest (Cycle 3), L.P. The percentage reported in row 11 herein is based on 105,410,089 shares of Common Stock of the Issuer outstanding, which is the sum of (i) 102,659,057 shares of Common Stock outstanding as of May 15, 2026, as reported by the Issuer in its proxy statement on Form DEF 14A, filed with the SEC on June 8, 2026, and (ii) an aggregate of 2,751,032 shares of Common Stock issuable upon the exercise of warrants held by all the reporting persons. The warrants contain provisions that prevent these securities from being exercised into shares of Common Stock, if such exercise would result in the holder or its affiliates obtaining greater than 9.99% of the Issuer's voting securities. Vivo Opportunity, LLC b DE 5305640.00 0.00 5305640.00 0.00 5305640.00 N 5.0 OO The reported share amount represents an aggregate of (i) 2,652,820 shares of Common Stock of the Issuer held by Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity Co-Invest, L.P. and Vivo Opportunity Co-Invest (Cycle 3), L.P., and (ii) 2,652,820 shares of Common Stock of the Issuer, which are issuable upon the exercise of certain warrants held by Vivo Opportunity Fund Holdings, L,P., Vivo Opportunity Co-Invest, L.P. and Vivo Opportunity Co-Invest (Cycle 3), L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity Co-Invest, L.P. and Vivo Opportunity Co-Invest (Cycle 3), L.P. The percentage reported in row 11 herein is based on 105,410,089 shares of Common Stock of the Issuer outstanding, which is the sum of (i) 102,659,057 shares of Common Stock outstanding as of May 15, 2026, as reported by the Issuer in its proxy statement on Form DEF 14A, filed with the SEC on June 8, 2026, and (ii) an aggregate of 2,751,032 shares of Common Stock issuable upon the exercise of warrants held by all the reporting persons. The warrants contain provisions that prevent these securities from being exercised into shares of Common Stock, if such exercise would result in the holder or its affiliates obtaining greater than 9.99% of the Issuer's voting securities. Vivo Opportunity Cayman Fund, L.P. b E9 196424.00 0.00 196424.00 0.00 196424.00 N 0.2 PN The reported share amount represents an aggregate of (i) 98,212 shares of Common Stock of the Issuer, and (ii) 98,212 shares of Common Stock of the Issuer, which are issuable upon the exercise of certain warrants. The shares of Common Stock and warrants are held of record by Vivo Opportunity Cayman Fund, L.P. Vivo Opportunity Cayman, LLC is the general partner of Vivo Opportunity Cayman Fund, L.P. The percentage reported in row 11 herein is based on 105,410,089 shares of Common Stock of the Issuer outstanding, which is the sum of (i) 102,659,057 shares of Common Stock outstanding as of May 15, 2026, as reported by the Issuer in its proxy statement on Form DEF 14A, filed with the SEC on June 8, 2026, and (ii) an aggregate of 2,751,032 shares of Common Stock issuable upon the exercise of warrants held by all the reporting persons. The warrants contain provisions that prevent these securities from being exercised into shares of Common Stock, if such exercise would result in the holder or its affiliates obtaining greater than 9.99% of the Issuer's voting securities. Vivo Opportunity Cayman, LLC b E9 196424.00 0.00 196424.00 0.00 196424.00 N 0.2 OO The reported share amount represents an aggregate of (i) 98,212 shares of Common Stock of the Issuer, and (ii) 98,212 shares of Common Stock of the Issuer, which are issuable upon the exercise of certain warrants. The shares of Common Stock and warrants are held of record by Vivo Opportunity Cayman Fund, L.P. Vivo Opportunity Cayman, LLC is the general partner of Vivo Opportunity Cayman Fund, L.P. The percentage reported in row 11 herein is based on 105,410,089 shares of Common Stock of the Issuer outstanding, which is the sum of (i) 102,659,057 shares of Common Stock outstanding as of May 15, 2026, as reported by the Issuer in its proxy statement on Form DEF 14A, filed with the SEC on June 8, 2026, and (ii) an aggregate of 2,751,032 shares of Common Stock issuable upon the exercise of warrants held by all the reporting persons. The warrants contain provisions that prevent these securities from being exercised into shares of Common Stock, if such exercise would result in the holder or its affiliates obtaining greater than 9.99% of the Issuer's voting securities. Achieve Life Sciences, Inc. 22722 29th Drive SE, Suite 100 Bothell, WA 98021 Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity Co-Invest, L.P. and Vivo Opportunity Co-Invest (Cycle 3), L.P. and their General Partner Vivo Opportunity, LLC Vivo Opportunity Cayman Fund, L.P. and its General Partner Vivo Opportunity Cayman, LLC 192 Lytton Avenue, Palo Alto, CA 94301 Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity Co-Invest, L.P. and Vivo Opportunity Co-Invest (Cycle 3), L.P. are Delaware limited partnerships. Vivo Opportunity, LLC is a Delaware limited liability company. Vivo Opportunity Cayman Fund, L.P. is a Cayman Islands limited partnership. Vivo Opportunity Cayman, LLC is a Cayman Islands limited liability company. Y Vivo Opportunity, LLC may be deemed to beneficially own an aggregate of 5,305,640 shares of the Issuer's securities, consisting of (i) 972,215 shares of Common Stock of the Issuer held of record by Vivo Opportunity Fund Holdings, L.P, 610,179 shares of Common Stock of the Issuer held of record by Vivo Opportunity Co-Invest, L.P., and 1,070,426 shares of Common Stock of the Issuer held of record by Vivo Opportunity Co-Invest (Cycle 3), L.P., and (ii) 972,215 shares of Common Stock of the Issuer, issuable upon exercise of certain warrants held of record by Vivo Opportunity Fund Holdings, L.P, 610,179 shares of Common Stock of the Issuer, issuable upon exercise of certain warrants held of record by Vivo Opportunity Co-Invest, L.P., and 1,070,426 shares of Common Stock of the Issuer, issuable upon exercise of certain warrants held of record by Vivo Opportunity Co-Invest (Cycle 3), L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity Co-Invest, L.P. and Vivo Opportunity Co-Invest (Cycle 3), L.P. Vivo Opportunity Cayman, LLC may be deemed to beneficially own an aggregate of 196,424 shares of the Issuer's securities, consisting of (i) 98,212 shares of Common Stock of the Issuer, and (ii) 98,212 shares of Common Stock of the Issuer, which are issuable upon the exercise of certain warrants. These securities are held of record by Vivo Opportunity Cayman Fund, L.P. Vivo Opportunity Cayman, LLC is the general partner of Vivo Opportunity Cayman Fund, L.P. The warrants of the reporting persons contain provisions that prevent these securities from being exercised into shares of Common Stock, if such exercise would result in the holder or its affiliates obtaining greater than 9.99% of the Issuer's voting securities. Vivo Opportunity Fund Holdings, L.P.: 1.8% Vivo Opportunity Co-Invest, L.P.: 1.2% Vivo Opportunity Co-Invest (Cycle 3), L.P. 2.0% Vivo Opportunity, LLC: 5.0% Vivo Opportunity Cayman Fund, L.P.: 0.2% Vivo Opportunity Cayman, LLC: 0.2% The percentage reported in this Item 4(b) is based on 105,410,089 shares of Common Stock of the Issuer outstanding, which is the sum of (i) 102,659,057 shares of Common Stock outstanding as of May 15, 2026, as reported by the Issuer in its proxy statement, filed with the SEC on June 8, 2026, and (ii) an aggregate of 2,751,032 shares of Common Stock issuable upon the exercise of warrants held by all the reporting persons herein. Vivo Opportunity Fund Holdings, L.P.: 1,944,430 shares Vivo Opportunity Co-Invest, L.P.: 1,220,358 shares Vivo Opportunity Co-Invest (Cycle 3), L.P.: 2,140,852 shares Vivo Opportunity, LLC: 5,305,640 shares Vivo Opportunity Cayman Fund, L.P.: 196,424 shares Vivo Opportunity Cayman, LLC: 196,424 shares 0 Vivo Opportunity Fund Holdings, L.P.: 1,944,430 shares Vivo Opportunity Co-Invest, L.P.: 1,220,358 shares Vivo Opportunity Co-Invest (Cycle 3), L.P.: 2,140,852 shares Vivo Opportunity, LLC: 5,305,640 shares Vivo Opportunity Cayman Fund, L.P.: 196,424 shares Vivo Opportunity Cayman, LLC: 196,424 shares 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ยง 240.14a-11. Exhibit 99.1 Joint Filing Statement Vivo Opportunity Fund Holdings, L.P. /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner 07/08/2026 Vivo Opportunity Co-Invest, L.P. /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner 07/08/2026 Vivo Opportunity Co-Invest (Cycle 3), L.P. /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner 07/08/2026 Vivo Opportunity, LLC /s/ Kevin Dai Kevin Dai/Managing Member 07/08/2026 Vivo Opportunity Cayman Fund, L.P. /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner 07/08/2026 Vivo Opportunity Cayman, LLC /s/ Kevin Dai Kevin Dai/Managing Member 07/08/2026